Endo, a wholly-owned subsidiary of Mallinckrodt plc, announced today the launch of ADRENALIN® (epinephrine in 0.9% sodium ...

Abstract: Peripheral intravenous catheters fail frequently, with some estimates of failure rates as high as 50% globally. In this letter, the potential for using force-sensitive resistors (FSRs) for ...

A Christchurch Hospital patient says she is “outraged” by a decision to disband a specialist intravenous (IV) access team that has been described as a lifeline for people with difficult-to-find veins.

1 Department of Operating Room Nursing, Huai’an Maternal and Child Health Care Hospital Affiliated to Yangzhou University, Huai’an, China 2 Department of Pediatric Surgery, Huai’an Maternal and Child ...

Bloodstream infection risk rises sharply after 3 days of peripheral IV catheter use, suggesting replacement by day 4 may help prevent serious complications. The risk of bloodstream infections (BSIs) ...

When deciding whether to use subcutaneous (SubQ) or intravenous (IV) therapies, clinicians must weigh several clinical and practical factors. One of the first considerations is the type of cancer ...

1. The risk of bloodstream infections (BSIs) in individuals with indwelling peripheral intravenous catheters (PIVCs) is significantly increased after 3 days of dwell time. Study Rundown: PIVCs are ...

Objective Billions of vascular access devices (VADs) are inserted annually for intravenous therapy worldwide. However, their use is not without challenges. Facilitating the process and enhancing ...

Objective: This study aims to evaluate the prognostic significance of peripheral blood biomarkers in relation to outcomes and immune-related adverse events (irAEs) among patients with stage IV driver ...